Sputnik V, the world‘s first COVID-19 vaccine, will be “highly effective” against the new coronavirus strain in Europe, said Kirill Dmitriev, chief executive officer (CEO) of the Russian Direct Investment Fund, the company that co-developed the vaccine Vaccine.
“According to our information, Sputnik V will be as effective against the new strain of the coronavirus occurring in Europe as it is against the existing strains. Sputnik V has shown its effectiveness for a certain period of time despite the previous mutations of the S protein,” he said, according to Sputnik Vs Twitter handle.
Mr Dmitriev added that it will partner with AstraZeneca, another vaccine manufacturer, to combat the new mutant strain of COVID-19.
“Working with a pharmaceutical giant like AstraZeneca becomes particularly important today as we tackle the new mutant strains of the coronavirus,” he said
The RDIF CEO also said the Sputnik V has been registered for use in Belarus.
Last week, Russian President Vladimir Putin said Sputnik V was over 95 percent effective.
The Russian Foreign Ministry (MFA) quoted Putin on Twitter, saying that some health specialists have claimed that the vaccine’s level of protection is as high as 96-97 percent.
Russia was the first country to register the world‘s first COVID-19 vaccine, named after Russia’s first satellite, on Aug. 11.